TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway and inhibits hypertension-induced cellular inflammation in endothelial cells via Ca2+/PI3K/Akt/eNOS/NO pathway [137]. Here, NOS3 is linked to hypertensive disorder.